GSK executives acquire shares in London and New York

GSK plc reported two senior personnel share transactions.

Rhea-AI Filing Summary

GSK plc reported two senior personnel share transactions. Independent Non-Executive Director Wendy Becker purchased 4,000 Ordinary Shares at £19.6291 each on the London Stock Exchange on 2026-04-29. Ordinary Shares have a nominal value of 31¼ pence.

Chief People Officer Diana Conrad acquired 12.874 American Depositary Shares at $54.5854 per ADS under the GSK pension plan on the New York Stock Exchange on 2026-04-27. Both transactions are disclosed as initial notifications of dealings by persons discharging managerial responsibilities.

Key Figures

Ordinary Shares purchased: 4,000 shares at £19.6291 ADS acquired under pension plan: 12.874 ADS at $54.5854 Ordinary Share nominal value: 31¼ pence each

3 metrics

Ordinary Shares purchased 4,000 shares at £19.6291 Wendy Becker transaction on 2026-04-29, London Stock Exchange

ADS acquired under pension plan 12.874 ADS at $54.5854 Diana Conrad transaction on 2026-04-27, New York Stock Exchange

Ordinary Share nominal value 31¼ pence each Description of GSK Ordinary Shares

Key Terms

PDMR, American Depositary Shares, LEI, Ordinary shares

4 terms

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

LEI regulatory

"b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

Ordinary shares financial

"Description of the financial instrument | Ordinary shares of 31 ¼ pence each"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider share purchases did GSK (GSK) disclose in this filing?

GSK disclosed that Independent Non-Executive Director Wendy Becker bought 4,000 Ordinary Shares at £19.6291 each, and Chief People Officer Diana Conrad acquired 12.874 American Depositary Shares at $54.5854 per ADS under the company’s pension plan on regulated exchanges.

Who is Wendy Becker and what GSK (GSK) share transaction did she make?

Wendy Becker is an Independent Non-Executive Director at GSK. She purchased 4,000 GSK Ordinary Shares of 31¼ pence each at a price of £19.6291 per share on 2026-04-29 through the London Stock Exchange, as an initial transaction notification.

What did GSK (GSK) Chief People Officer Diana Conrad acquire in this report?

Chief People Officer Diana Conrad acquired 12.874 GSK American Depositary Shares under the GSK pension plan. The ADS were purchased at $54.5854 each on 2026-04-27 on the New York Stock Exchange, and the dealing is reported as a single, aggregated transaction.

On which exchanges were the reported GSK (GSK) transactions executed?

Wendy Becker’s purchase of 4,000 GSK Ordinary Shares occurred on the London Stock Exchange (XLON). Diana Conrad’s acquisition of 12.874 American Depositary Shares took place on the New York Stock Exchange (XNYS), both being standard market transactions on major exchanges.

What types of GSK (GSK) securities were involved in these insider dealings?

The filing involves two GSK security types: Ordinary Shares of 31¼ pence each with ISIN GB00BN7SWP63, and American Depositary Shares with ISIN US37733W2044. Becker bought Ordinary Shares, while Conrad acquired ADS through participation in the company’s pension plan.

Why are these GSK (GSK) transactions described as PDMR notifications?

They are PDMR notifications because both individuals are persons discharging managerial responsibilities at GSK. Regulations require reporting their dealings in company securities, including Becker’s share purchase and Conrad’s ADS acquisition under the pension plan, as initial notifications of transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 12:00 PM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Wendy Becker
b)	Position/status	Independent Non-Executive Director
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	Purchase of 4,000 Ordinary Shares
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£19.6291	4,000
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-04-29
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Diana Conrad
b)	Position/status	Chief People Officer
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of ADS under GSK pension plan
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$54.5854	12.874
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-04-27
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: April 29, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc